The FDA approved a new drug in the fight against Alzheimer’s disease earlier this month. It’s called Leqembi and is most effective for those with mild symptoms.

On Wellness Monday, “News All Day” was joined by Dr. Mary Sano, director of the Alzheimer’s Disease Research Center at the Icahn School of Medicine at Mount Sinai.

The drug was given “Accelerated Approval” which means it works on the biology of Alzheimer’s disease. It removes amyloid, which is a protein in the brain that is responsible for the disease.

Sano suggests speaking with a doctor if you find that you’re experiencing memory symptoms to see if you have reason to be concerned.

The drug is infused twice per month. It is likely to cause a rash at the site. Another downside could include a brain change, like a minor stroke in the brain. You should speak with your doctor to see if this is the right medication for you.

For more information, go to